Leonard Braden Michael

Average Profitability
<0.0001%
Insider Buys Quantity
72
Insider Buys Sum
$16.21M
Insider Sells Quantity
51
Insider Sells Sum
$28.82M

Insider Activity of Leonard Braden Michael

According to the SEC Form 4 filings, Leonard Braden Michael, being in a position of

  1. 10 percent owner at Aclaris Therapeutics, Inc.,
    оver the last 12 months, has bought 4854052 shares for $5.59M, and sold 0 shares,
    over all time since 2024-06-11, has bought 4854052 shares for $5.59M, and sold 0 shares.

The largest purchase of all time was on 2024-08-14 and amounted to 1500000 shares of AN2 Therapeutics, Inc. for $1.56M.

The largest sale of all time was on 2022-12-29 and amounted to 3000000 shares of Retractable Technologies, Inc. for $4.8M.

Biography of Leonard Braden Michael

No biography is available at this moment.

2024-09-06PurchaseTalis Biomedical Corporation
TLIS
10 percent owner
25,000
0.3968%
$1.48$37,100+12.9%
2024-09-05PurchaseTalis Biomedical Corporation
TLIS
10 percent owner
5,100
0.0764%
$1.40$7,140+19.86%
2024-09-03PurchaseTalis Biomedical Corporation
TLIS
10 percent owner
500
0.0251%
$4.00$2,000-53.21%
2024-08-30PurchaseTalis Biomedical Corporation
TLIS
10 percent owner
151
0.008%
$4.25$642-60.05%
2024-08-28PurchaseTalis Biomedical Corporation
TLIS
10 percent owner
1,215
0.0645%
$3.96$4,815-57.32%
2024-08-26PurchaseTalis Biomedical Corporation
TLIS
10 percent owner
13,167
0.6969%
$3.90$51,322-56.68%
2024-08-14PurchaseAN2 Therapeutics, Inc.
ANTX
10 percent owner
1.5M
3.1264%
$1.04$1.56M+2.38%
2024-08-05PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
206,025
0.2901%
$1.24$256,357-2.42%
2024-08-02PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
167,544
0.2372%
$1.29$216,400-5.47%
2024-07-31PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
100,000
0.1421%
$1.33$132,640-0.48%
2024-07-30PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
173,730
0.2425%
$1.30$226,370+1.3%
2024-07-30PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
85,800
0.3983%
$7.15$613,470+5.87%
2024-07-22PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
17,716
0.0249%
$1.33$23,557-8.27%
2024-07-19PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
6,689
0.0092%
$1.30$8,696-7.58%
2024-07-18PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
130,317
0.1816%
$1.30$169,555-6.11%
2024-07-18PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
80,718
0.3739%
$9.11$735,737-25.63%
2024-07-17PurchaseAdverum Biotechnologies, Inc.
ADVM
10 percent owner
135,546
0.5761%
$7.75$1.05M-19.7%
2024-07-05PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
123,017
0.1779%
$1.15$141,3340%
2024-07-03PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
143,288
0.209%
$1.16$166,0710%
2024-07-02PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
86,092
0.1239%
$1.14$98,4890%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.